Amphastar Pharma Q4 EPS $0.88 Misses $0.91 Estimate, Sales $178.10M Beat $175.67M Estimate
Portfolio Pulse from Happy Mohamed
Amphastar Pharma (NASDAQ:AMPH) reported Q4 earnings of $0.88 per share, missing the consensus estimate of $0.91 by 3.3%. However, their quarterly sales of $178.10M exceeded the estimate of $175.67M by 1.39%, marking a 31.91% increase from the previous year.
February 28, 2024 | 9:25 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Amphastar Pharma's Q4 earnings per share missed estimates by 3.3%, but sales exceeded expectations, showing significant year-over-year growth.
While the miss in earnings per share (EPS) might concern some investors, the beat on sales and the significant year-over-year growth could offset negative sentiment. The mixed results present a neutral short-term outlook as the market digests both the earnings miss and the sales beat.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100